These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12163399)

  • 1. Apparent KIT Ser(715) deletion in GIST mRNA is not detectable in genomic DNA and represents a previously known splice variant of KIT transcript.
    Lasota J; Kopczynski J; Majidi M; Miettinen M; Sarlomo-Rikala M
    Am J Pathol; 2002 Aug; 161(2):739-41. PubMed ID: 12163399
    [No Abstract]   [Full Text] [Related]  

  • 2. KIT gene mutations in gastrointestinal stromal tumors: more complex than previously recognized?
    Fletcher JA; Fletcher CD; Rubin BP; Ashman LK; Corless CL; Heinrich MC
    Am J Pathol; 2002 Aug; 161(2):737-8; author reply 738-9. PubMed ID: 12163398
    [No Abstract]   [Full Text] [Related]  

  • 3. A mutation-created novel intra-exonic pre-mRNA splice site causes constitutive activation of KIT in human gastrointestinal stromal tumors.
    Chen LL; Sabripour M; Wu EF; Prieto VG; Fuller GN; Frazier ML
    Oncogene; 2005 Jun; 24(26):4271-80. PubMed ID: 15824741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of c-kit gene mutation on prognosis of gastrointestinal stromal tumor].
    Ma DL; Liu XH; Bai CG; Xie Q; Feng F
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):140-4. PubMed ID: 15062057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR.
    Bernet L; Zuñiga A; Cano R
    Rev Esp Enferm Dig; 2003 Oct; 95(10):688-91, 683-7. PubMed ID: 14588063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of loss-of-function and gain-of-function mutations of c-kit on the gastrointestinal tract.
    Hirota S; Isozaki K; Nishida T; Kitamura Y
    J Gastroenterol; 2000; 35 Suppl 12():75-9. PubMed ID: 10779223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients.
    Kinoshita K; Hirota S; Isozaki K; Ohashi A; Nishida T; Kitamura Y; Shinomura Y; Matsuzawa Y
    J Pathol; 2004 Jan; 202(1):80-5. PubMed ID: 14694524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New activating mutation in GI stromal tumors.
    Lang L
    Gastroenterology; 2003 Mar; 124(3):596. PubMed ID: 12612892
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis of c-kit gene mutations in gastrointestinal stromal tumors].
    Hou YY; Sun MH; Tan YS; Wei YK; Lu XY; Zhang TM; Du X; Wang J; Zhu XZ
    Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):89-92. PubMed ID: 15059325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and mutation of c-kit gene in gastrointestinal stromal tumor].
    Ma D; Liu X; Cai Z; Xie Q
    Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):461-4. PubMed ID: 12485499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.
    Rubin BP; Singer S; Tsao C; Duensing A; Lux ML; Ruiz R; Hibbard MK; Chen CJ; Xiao S; Tuveson DA; Demetri GD; Fletcher CD; Fletcher JA
    Cancer Res; 2001 Nov; 61(22):8118-21. PubMed ID: 11719439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT.
    Bauer S; Corless CL; Heinrich MC; Dirsch O; Antoch G; Kanja J; Seeber S; Schütte J
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):261-5. PubMed ID: 12655446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors.
    Chen LL; Trent JC; Wu EF; Fuller GN; Ramdas L; Zhang W; Raymond AK; Prieto VG; Oyedeji CO; Hunt KK; Pollock RE; Feig BW; Hayes KJ; Choi H; Macapinlac HA; Hittelman W; Velasco MA; Patel S; Burgess MA; Benjamin RS; Frazier ML
    Cancer Res; 2004 Sep; 64(17):5913-9. PubMed ID: 15342366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of c-kit-activating mutations in gastrointestinal stromal tumors by high-resolution amplicon melting analysis.
    Willmore C; Holden JA; Zhou L; Tripp S; Wittwer CT; Layfield LJ
    Am J Clin Pathol; 2004 Aug; 122(2):206-16. PubMed ID: 15323137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastrointestinal stromal tumors].
    Schlemmer M; Milani V; Tschoep K; Fahn W; Wendtner CM
    Dtsch Med Wochenschr; 2003 Sep; 128(39):2015-9. PubMed ID: 14508696
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinicopathological features of gastric stromal tumors.
    Nishida T; Nakamura J; Taniguchi M; Hirota S; Ito T; Kitamura Y; Matsuda H
    J Exp Clin Cancer Res; 2000 Dec; 19(4):417-25. PubMed ID: 11277317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late resistance to imatinib therapy in a metastatic gastrointestinal stromal tumour is associated with a second KIT mutation.
    Wakai T; Kanda T; Hirota S; Ohashi A; Shirai Y; Hatakeyama K
    Br J Cancer; 2004 Jun; 90(11):2059-61. PubMed ID: 15150562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent progress in gastrointestinal stromal tumor (GIST)].
    Horiuchi H; Matsuya S; Konishi T
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1495-501. PubMed ID: 12355934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant.
    Wardelmann E; Neidt I; Bierhoff E; Speidel N; Manegold C; Fischer HP; Pfeifer U; Pietsch T
    Mod Pathol; 2002 Feb; 15(2):125-36. PubMed ID: 11850541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours.
    Hirota S; Nishida T; Isozaki K; Taniguchi M; Nakamura J; Okazaki T; Kitamura Y
    J Pathol; 2001 Apr; 193(4):505-10. PubMed ID: 11276010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.